The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.
Intraperitoneal (IP) administration of the glutaramic acid derivative proglumide inhibited satiety induced by all IP doses of cholecystokinin octapeptide (CCK-OP) in 3-hour food-deprived intact rats. Proglumide did not influence satiety when administered alone and did not inhibit satiety induced by IP glucagon. While proglumide did not inhibit satiety induced by low doses of IP bombesin, it partially and significantly inhibited the satiety effects produced by high doses of this peptide. Since bombesin is a known secretagogue for CCK in several species, these results indicate that while bombesin and CCK act independently to induce satiety, the effect induced by high doses of bombesin is mediated, in part, by the release of endogenous CCK or a structurally related peptide. Furthermore, these results illustrate that proglumide is a specific antagonist of CCK-induced satiety and is, therefore, a potentially useful tool for investigating the physiologic role of this peptide in the control of food intake.
D000818:Animals; D001066:Appetite / Q000187:drug effects*; D001839:Bombesin / Q000494:pharmacology*; D002766:Cholecystokinin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005508:Food Deprivation; D005934:Glucagon / Q000494:pharmacology*; D005973:Glutamine / Q000031:analogs & derivatives*; D008297:Male; D010455:Peptides / Q000494:pharmacology*; D011377:Proglumide / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D010455:Peptides; D005973:Glutamine; D005934:Glucagon; D002766:Cholecystokinin; D011377:Proglumide; D001839:Bombesin